Cancer

Metabolic dysfunction-associated steatotic liver disease (MASLD) and the encompassing category of steatotic liver disease (SLD) are emerging as critical public...

The Broad Institute’s Cancer Dependency Map Consortium (DMC) is poised to revolutionize the field of oncology with the launch of...

Chimeric antigen receptor (CAR) T cell therapy is revolutionizing the treatment landscape of hematological malignancies, presenting a potent, targeted immunotherapeutic...

In the relentless battle against breast cancer, one of the most formidable obstacles remains endocrine resistance, particularly within hormone receptor–positive...

In a groundbreaking study recently published in Nature Communications, researchers from the Institute for Systems Biology (ISB) have shed new...

In a groundbreaking study poised to reshape the future of dermatological care, researchers from the University of Gothenburg and Chalmers...

In an extraordinary breakthrough, researchers have unveiled critical insights into the enigmatic relationship between Notch and TGF-β signaling pathways in...

In a significant development poised to reshape prognostic methodologies in oncology, a new commentary published in the British Journal of...

SAN DIEGO, CA – At the forefront of cancer research and innovation, the Abramson Cancer Center (ACC) and the Perelman...

Colorectal cancer remains a formidable challenge in oncology, largely because of its high rate of relapse despite advances in surgery,...